Business / Finance

RSS

Physicians Realty Trust prices public offering of common stock at $12.50 per share

Physicians Realty Trust ("the Company"), a self-managed healthcare real estate company, announced today the pricing of its public offering of 11,000,000 common shares of beneficial interest at a price to the public of $12.50 per share, for a total of approximately $129.5 million of net proceeds after deducting underwriting discounts and commissions and estimated offering expenses payable by the Company.

21 May 2014

Lucideon invests in an Agilent 7900 Quadrapole ICP-MS to extend its analysis techniques offerings

Lucideon, the international provider of materials development, testing and assurance, and formerly known as Ceram, is pleased to announce it has invested in the latest Agilent 7900 Quadrapole Inductively Coupled Plasma – Mass Spectrometry (ICP-MS).

From Lucideon 21 May 2014

Edison Pharmaceuticals' EPI-743 granted orphan designation for Leigh syndrome in Japan

Edison Pharmaceuticals has announced that the Japanese Ministry of Health, Labor and Welfare (MHLW) has granted Orphan Designation to EPI-743 for the treatment of Leigh syndrome.

21 May 2014

FDA approves Takeda's Entyvio for severe active ulcerative colitis and Crohn's disease

Takeda Pharmaceutical Company Limited and its wholly-owned subsidiary, Takeda Pharmaceuticals U.S.A., Inc., has announced that the United States (U.S.) Food and Drug Administration (FDA) simultaneously approved a new biologic therapy, Entyvio™ (vedolizumab), for the treatment of adults with moderately to severely active ulcerative colitis (UC) and Crohn's disease (CD).

21 May 2014

Marijuana Incubator Group to acquire VaporTownUsa.com

Marijuana Incubator Group, Inc. is pleased to announce that the Company has entered into meaningful negotiations for the purchase of VaporTownUsa.com, a profitable online vendor of top quality vapor related essentials.

20 May 2014

Cardiome, AOP Orphan team up to commercialize AGGRASTAT in select European markets

Cardiome Pharma Corp. today announced an agreement with AOP Orphan Pharmaceuticals AG, headquartered in Vienna, Austria, to commercialize AGGRASTAT® (tirofiban HCl) in selected European markets.

20 May 2014

BioLineRx announces financial results for Q1 2014, provides operational update

BioLineRx, a clinical-stage biopharmaceutical company dedicated to identifying, in-licensing and developing promising therapeutic candidates, today reported its financial results for first quarter ended March 31, 2014.

20 May 2014

Proteo Biotech, BDC sign deal to develop orphan medicinal product Tiprelestat

Proteo Inc. announced today that its German subsidiary, Proteo Biotech AG, has entered into an agreement with the US company Biotech Development Corp. (BDC).

20 May 2014

Avita Health System to use NextGen solutions to track and enhance patient care

NextGen Healthcare Information Systems, LLC., a wholly owned subsidiary of Quality Systems, Inc. and a leading provider of healthcare information systems and connectivity solutions, announced today an agreement with Avita Health System for the deployment of a range of NextGen® solutions across its extensive enterprise.

20 May 2014

Orexo US partners with inVentiv Health to market Zubsolv sublingual tablets in the US

Orexo AB announces a new partnership between Orexo US, Inc. and inVentiv Health for the commercialization of Zubsolv in the US.

20 May 2014

DNA-directed RNA interference and hepatitis C: an interview with Carl Stubbings, Chief Business Officer, Benitec Biopharma

RNA interference (RNAi) is a naturally occurring process, which cells can use to silence, or ‘turn off’ unwanted genes.

From Quest Diagnostics 19 May 2014

Endo acquires worldwide rights to Zogenix' sumatriptan injection

Endo International plc announced today that affiliates of the company have completed the acquisition of worldwide rights to Sumavel® DosePro® (sumatriptan injection), a needle-free delivery system for subcutaneous use, from Zogenix, Inc, for $85 million in cash and rights to additional cash payments based on the achievement of certain commercial milestones.

19 May 2014

KineMed extends collaboration with CHDI Foundation to track pathogenesis of Huntington's disease

KineMed, Inc. and CHDI Foundation, Inc. announced today an extension of their collaboration that uses KineMed's translational biomarker platform to characterize and track the pathogenesis of Huntington's disease (HD) and evaluate potentially therapeutic interventions.

19 May 2014

Bio-Path Holdings reports net loss of $504,876 for first quarter 2014

Bio-Path Holdings, Inc., a biotechnology company developing a liposomal delivery technology for nucleic acid cancer drugs, today announced operational and financial results for the first quarter ended March 31, 2014.

17 May 2014

Abbott signs definitive agreement to acquire CFR Pharmaceuticals

Abbott today announced a definitive agreement to acquire Latin American pharmaceutical company CFR Pharmaceuticals, more than doubling its Latin American branded generics pharmaceutical presence and further expanding Abbott's presence in fast-growing markets.

16 May 2014

Provectus’ shares to begin trading on NYSE MKT on May 16, 2014

Provectus Biopharmaceuticals, Inc., a development-stage oncology and dermatology biopharmaceutical company, announced that its shares will begin trading on the NYSE MKT today, Friday, May 16, 2014.

16 May 2014

Kymab raises US$40 million in Series B financing

Kymab, a monoclonal antibody biopharmaceutical company, announced today it has successfully raised US$40 million in a Series B financing.

16 May 2014

Standard & Poor's upgrades HTA's investment grade credit rating to BBB

Healthcare Trust of America, Inc. (NYSE: HTA) announced today that Standard & Poor's ("S&P") has upgraded HTA's investment grade credit rating to BBB, with a stable outlook.

16 May 2014

Agfa HealthCare launches ICIS for mobile and web capture at SIIM 2014, extending the "Evolution of Visual Healthcare" to smart phones and tablets

Extending the "Evolution of Visual Healthcare" to mobile devices, Agfa HealthCare announced today the launch of its new web-enabled mobile image management technology that brings the power of ICIS to iPhones, iPads, Web, and Android mobile digital devices.

15 May 2014

Actavis reaches agreement to continue supplying authorized generic version of JPI's Concerta

Actavis plc today announced that it has reached an agreement with Janssen Pharmaceuticals, Inc. to continue supplying the authorized generic version of JPI's Concerta (methylphenidate hydrochloride extended-release tablets).

15 May 2014

Business / Finance

Physicians Realty Trust prices public offering of common stock at $12.50 per share

Lucideon invests in an Agilent 7900 Quadrapole ICP-MS to extend its analysis techniques offerings

Edison Pharmaceuticals' EPI-743 granted orphan designation for Leigh syndrome in Japan

FDA approves Takeda's Entyvio for severe active ulcerative colitis and Crohn's disease

Marijuana Incubator Group to acquire VaporTownUsa.com

Cardiome, AOP Orphan team up to commercialize AGGRASTAT in select European markets

BioLineRx announces financial results for Q1 2014, provides operational update

Proteo Biotech, BDC sign deal to develop orphan medicinal product Tiprelestat

Avita Health System to use NextGen solutions to track and enhance patient care

Orexo US partners with inVentiv Health to market Zubsolv sublingual tablets in the US

DNA-directed RNA interference and hepatitis C: an interview with Carl Stubbings, Chief Business Officer, Benitec Biopharma

Endo acquires worldwide rights to Zogenix' sumatriptan injection

KineMed extends collaboration with CHDI Foundation to track pathogenesis of Huntington's disease

Bio-Path Holdings reports net loss of $504,876 for first quarter 2014

Abbott signs definitive agreement to acquire CFR Pharmaceuticals

Provectus’ shares to begin trading on NYSE MKT on May 16, 2014

Kymab raises US$40 million in Series B financing

Standard & Poor's upgrades HTA's investment grade credit rating to BBB

Agfa HealthCare launches ICIS for mobile and web capture at SIIM 2014, extending the "Evolution of Visual Healthcare" to smart phones and tablets

Actavis reaches agreement to continue supplying authorized generic version of JPI's Concerta

Leveraging the Radian ASAP in standard casework

A journey through science, software, and innovation: Insights from the Bruker software team

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Latest News